Fluticasone propionate

Armonair Digihaler, Armonair Respiclick, Cutivate, Flonase, Flonase Relief, Flovent, Flovent Diskus, Flovent Hfa, Xhance, BroPair Spiromax, Seffalair Spiromax (fluticasone propionate) is a small molecule pharmaceutical. Fluticasone propionate was first approved as Armonair Digihaler on 1990-12-14. It is used to treat allergic rhinitis perennial in the USA. It has been approved in Europe to treat asthma. The pharmaceutical is active against glucocorticoid receptor. In addition, it is known to target mineralocorticoid receptor and progesterone receptor. Advair diskus's patents are valid until 2038-12-18 (FDA).